What Canadians Need to Know About Each Authorized COVID-19 Vaccine


TORONTO – Canada is expecting to receive more than two million doses of Pfizer-BioNTech COVID-19 vaccines each week through June, and Moderna is expected to receive one million additional doses next week. With four COVID-19 vaccines now authorized for use in Canada, which vaccines will be eligible to receive them and where can they obtain them?

COVID-19 vaccines that are still authorized for use in Canada are Pfizer-BioNotech, Modern, AstraZeneca and Johnson & Johnson. To date, more than 14 million doses have been administered nationwide. With Canada set to receive larger doses in the coming weeks, Granthshala.ca has outlined which groups are recommended to be eligible to receive which vaccines, where they will be able to receive it , And how many dates have been received by Canada. Will be received in the future.

Decisions around eligibility are made at the provincial level, which are informed by recommendations from the National Advisory Committee on Immunization (NACI).

PFIZER-BIONTECH

Health Canada Authorized Pfizer On December 9, 2020, the vaccine was the first vaccine approved in Canada to prevent COVID-19. The two-shot mRNA vaccine is authorized for Canadians who are 16 years of age and older, and has been introduced in hospitals, mass vaccination clinics, and pop-up clinics.

The government first began distributing Pfizer vaccine supplements in December 2020, and until last week, More than 9.5 million doses delivered Across the country. While Canada was receiving more than one million doses every week in April, with Canada receiving more than two million doses a week by the beginning of July, supplies to Canada will double, a boost for the government to reach the goal of all Will give. Adults were vaccinated by the end of September. With the incoming shipment of doses, NACI stated that the four-month waiting period before the first and second doses could be reduced to a waiting period of 1.5 to two months as well.

till now, Government has invested up to 76 million Pfizer COVID-19 vaccine.

modern

MRNA modern The vaccine was authorized by Health Canada on December 23, 2020 for individuals who are over 18 years of age. Similar to Pfizer, two-shot vaccines have been offered at local hospitals, mass vaccination clinics and pop-up clinics.

The shipment of the modern vaccine arrived a day after Health Canada’s approval and was first distributed in the north of Canada. As of last week, approximately 2.9 million doses of modern have been allocated across the country, with Canada expected to receive approximately one million more doses next week.

Currently, the government has entered into an agreement with the pharmaceutical company for 44 million doses.

ASTRAZENECA

AstraZeneca The vaccine – known scientifically as ChAdOx1-S, is manufactured by AstraZeneca and Serum Institute of India, which calls its own brand of vaccine COVISHIELD. The vaccine and both manufacturers were approved by Health Canada on 26 February. The adenovirus vector vaccine is given in two doses, and while the vaccine was previously authorized for Canadians who are 18 years of age and older, the age at which the NACI has made recommendations should the group receive this vaccine. In March, AstraZeneca was recommended to Canadians over the age of 65, although NACI has now extended eligibility to include more Canadians and is now recommending the vaccine to anyone 30 and older. If they do not want to wait an mRNA inoculation.

Vaccines are currently being offered in pharmacies, walk-in appointments are offered in many locations and COVID-19 vaccines are more accessible to Canadians.

The AstraZeneca vaccine was first distributed in Canada in March, and as of last week, approximately 2.3 million doses have been distributed throughout the country. With the exception of Northwest Territories and Nunavut, all provinces and territories have received shipments of this vaccine.

By combining the two manufacturers, the government has achieved a total of 22 million doses of AstraZeneca.

Johnson and johnson

Johnson and johnson The COVID-19 vaccine was authorized by Health Canada on 5 March. It is a single-dose, adenovirus vector vaccine. The vaccine is approved for Canadians who are 18 years of age and older, but similar to NACI’s suggestions with AstraZeneca, the Johnson & Johnson vaccine is recommended for individuals 30 and older and For those individuals who do not want to wait. An mRNA vaccine.

NACI also recommends using a one-shot vaccine for populations for which it may be more difficult to schedule a second dose. Experts say this may include experience of living in shelters or being homeless, and that in addition to single-dose vaccines, more pop-up clinics may also form.

Last Wednesday, a consignment of 300,000 Johnson & Johnson supplements arrived in Canada, although Health Canada has since occupied the dose for potential concerns with quality control and no shots are currently available to Canada.

For Johnson & Johnson, the government has agreed to purchase 38 million doses of the vaccine from the manufacturer.

other facilities

While the vaccines have not yet been approved by Health Canada, the government has invested in three additional suppliers of two-dose COVID-19 vaccines: Medicago, Novavax, and Sanofi and GlaxoSmithKline. The government has agreed to purchase 76 million for each of the Medicogo and Novavax vaccines and up to 72 million doses of the Sanofi and GlaxoSmithKline vaccines, if they are authorized for use here.

.

Latest articles

Related articles